
Accendra Health, Inc.: dividend
Price
$0.13
November 13, 2026Market cap $10M
What Ploutos Investor adds for Accendra Health
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 57% since Nov 5, 2026, when the 10-Q these figures come from was filed ($0.30 then, $0.13 on Nov 13, 2026). The figures date from before that move.10-Q
Accendra Health pays no dividend
It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 100.89% of market cap in the latest fiscal year.
All dividend stocksEverything it returns to shareholders
The dividend is one way. The other is buybacks, which reduce the number of shares.
Dividend yield
0.00%
Buybacks
100.89%
$1,008.90 a year per $1,000 of shares
The share count fell by 1.1% over the year.
Total returned
100.89%
$1,008.90 a year per $1,000 of shares
dividend 0%buybacks 100%
The full analysis
What do Accendra Health's filings show?
The dividend is one part of Accendra Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Does ACH pay a dividend?
It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 100.89% of market cap in the latest fiscal year.
How does ACH return money to shareholders?
Accendra Health pays no dividend. Its buybacks in the latest fiscal year came to 100.89% of market cap.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.